Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial

Saunders, P; Tsipouri, V; Keir, GJ; Ashby, D; Flather, MD; Parfrey, H; Babalis, D; Saunders, P; Tsipouri, V; Keir, GJ; Ashby, D; Flather, MD; Parfrey, H; Babalis, D; Renzoni, EA; Denton, CP; Wells, AU; Maher, TM; - view fewer (2017) Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial. Trials , 18 , Article 275. 10.1186/s13063-017-2016-2 . Green open access

http://ift.tt/2u5bSqF